Extracorporeal photochemotherapy for secondary chronic progressive multiple sclerosis: A pilot study

Photodermatology Photoimmunology and Photomedicine

Volumn 18, Issue 1, 2002, Pages 36-41

  Besnier, D P ^a   Chabannes, D ^a   Mussini, J M G ^a   Dupas, B ^a   Esnault, V L M ^a,b  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b HÔTEL DIEU   (France)

Author keywords

Extracorporeal photochemotherapy; Multiple sclerosis; Photopheresis; Psoralene; UVA

Indexed keywords

AZATHIOPRINE; BETA INTERFERON; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHOXSALEN; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY;

ADULT; ALLOIMMUNITY; APLASIA; ARTICLE; AUTOIMMUNITY; CELL SEPARATION; CELL SUSPENSION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEPATITIS; HUMAN; IMMUNE DEFICIENCY; MALE; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; PHOTOCHEMOTHERAPY; PILOT STUDY; PRIORITY JOURNAL; PUVA; RECURRENT DISEASE; RELAPSE; SCORING SYSTEM; ULTRAVIOLET A RADIATION;

ADULT; CHRONIC DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PHOTOPHERESIS; PILOT PROJECTS;

EID: 0036114230     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0781.2002.180106.x     Document Type: Article

References (32)

1. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
2. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients
3. A myelin basic protein-specific T lymphocyte line that mediates experimental autoimmune encephalomyelitis
4. Restricted T-cell receptor Vβ gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis: Predominant genes vary in individuals
5. In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis
6. Choosing drug therapy for multiple sclerosis. An update
7. Modified total lymphoid irradiation and low dose corticosteroids in progressive multiple sclerosis
8. Randomised double-blind placebo-controlled study of interferon beta-la in relapsing/remitting multiple sclerosis
9. Evidence of interferon beta-la dose-response in relapsing-remitting MS
10. Population based cost utility study of interferon beta-la in secondary progressive multiple sclerosis
11. Interferon gamma, IL2, IL4, IL10 and TNFalpha secretions in multiple sclerosis patients treated with an anti-CD4 monoclonal antibody
12. Effects of anti-CD4 antibody treatment on lymphocyte subsets and stimulated tumor necrosis factor alpha production: A study of 29 multiple sclerosis patients entered into a clinical trial of cM-T412
13. Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis
14. Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation
15. PUVA therapy for chronic cutaneous graft-vs-host disease
16. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy: Preliminary results
17. Review of immunomodulation by photopheresis: Treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection
18. Treatment of graft-versus-host disease by extracorporeal photochemotherapy: A pilot study
19. Photopheresis versus corticosteroids in the treatment of heart transplant rejection: Preliminary clinical report
20. Reduction of the incidence of rejection by adjunct immunosuppression with photochemotherapy after heart transplantation
21. Photophoresis for the prevention of rejection in cardiac transplantation
22. Successful treatment of recurrent rejection in renal transplant patients with photopheresis
23. Photopheresis for chronic rejection of lung allografts
24. Extracorporeal photochemotherapy: Evaluation of two techniques and use in connective tissue disorders
25. A double-blind, placebo-controlled trial of extracorporeal photopheresis in chronic progressive multiple sclerosis
26. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
27. Multiple sclerosis, the impact of MR imaging
28. Variation between observers in classifying multiple sclerosis
29. More immunotherapy for multiple sclerosis
30. Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes
31. Specific vaccination against photoinactivated cloned T cells
32. Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein